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Cellular responses to hormones and neurotransmit-
ters are necessarily transient. The mating pheromone
signal in yeast is typical. Signal initiation requires cell
surface receptors, a G protein heterotrimer, and down-
stream effectors. Signal inactivation requires Sst2, a
regulator of G protein signaling (RGS) protein that ac-
celerates GTPase activity. We conducted a quantitative
analysis of RGS and G protein expression and devised
computational models that describe their activity in
vivo. These results indicated that pheromone-dependent
transcriptional induction of the RGS protein constitutes
a negative feedback loop that leads to desensitization.
Modeling also suggested the presence of a positive feed-
back loop leading to resensitization of the pathway. In
confirmation of the model, we found that the RGS pro-
tein is ubiquitinated and degraded in response to pher-
omone stimulation. We identified and quantitated these
positive and negative feedback loops, which account for
the transient response to external signals observed in
vivo.
One measure of our understanding of biological systems is
our ability to predict their behavior in detail. One aspect of this
endeavor is to model signal transduction events, defined here
as the dynamic changes that occur within a cell in response to
an external stimulus (1–3). Such models can help us to under-
stand how small changes outside a cell produce strongly am-
plified changes within a cell, how graded signals are converted
to all-or-none responses (4), or how activators of one pathway
influence the function of a second pathway (5). A second goal,
and the focus of this work, is to understand how transient
external signals are prevented from being propagated indefi-
nitely within the cell. Here we describe the molecular basis for
signal activation, desensitization, and eventual resensitization
of G proteins by receptors and RGS1 proteins. The experimen-
tally observed behavior is described mechanistically by compu-
tational modeling of the pathway.
For these studies we investigated the mating pheromone
signaling pathway in yeast Saccharomyces cerevisiae. The
yeast mating response is arguably the best characterized signal
transduction pathway of any eukaryote, and it has long served
as a prototype for hormone, neurotransmitter, and sensory
response systems in humans (6). Disruption or activation of
pathway components leads to highly specific changes that can
be easily quantified. Finally, because it is a unicellular eu-
karyote, every cell in a population is genetically and phenotyp-
ically identical (all cells are “typical”).
Mating in yeast is the fusion of a and  haploid cell types to
form an a/ diploid. The events leading to fusion are initiated
by specific pheromones: -type cells secrete -factor phero-
mone, which binds to a specific receptor (Ste2) on a-cells, while
a-cells secrete a-factor that binds to receptors (Ste3) on -cells.
Upon pheromone binding to its receptor, the G protein  sub-
unit (Gpa1) releases GDP, binds to GTP, and liberates the G
protein  subunits (Ste4/Ste18). Sustained signaling requires
multiple effectors that bind to the dissociated G (7) and G
components (8). These effectors go on to activate a mitogen-
activated protein kinase cascade, leading to new gene tran-
scription, morphological changes, cell division arrest, and ulti-
mately cell fusion to form the a/ diploid (6). Following GTP
hydrolysis, the G protein subunits reassociate and signaling
stops (9).
One of the pheromone-induced genes encodes the prototype
RGS protein Sst2. We have shown previously that Sst2 inter-
acts genetically (10, 11) and physically (12) with Gpa1 and can
accelerate its GTPase activity more than 40-fold (13). Mutants
lacking SST2 are 100-fold more sensitive to pheromone (12,
14, 15). This pattern of induction and regulation of pheromone
signaling suggests that Sst2 is part of a feedback inhibition
loop that promotes desensitization. Although intuitively rea-
sonable, this concept has never been tested explicitly. More-
over, while computational models of G protein activation and
inactivation have been devised previously, they have not been
rigorously tested in vivo due to a lack of information about
expression levels or about specificity of coupling of receptors
and G proteins (3, 16). Here we devise a detailed model that
describes the behavior of cells treated with pheromone and
demonstrate the predictive power of that model through
experimentation.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for the growth, mainte-
nance, and transformation of yeast and bacteria and for the manipula-
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tion of DNA were used throughout (17). The yeast S. cerevisiae strains
used in this study were BY4741 (MATa leu2 met15 ura3) or
BY4741-derived deletion mutants lacking sst2, ubr1, ubc2/rad6, ubc4,
ubc5, ubc7/qri8, ubc8, ubc10/pex4, ubc11, ubc12, and ubc13 (Research
Genetics, Huntsville, AL). UBC-related gene deletion mutants not
tested were ubc1 (inviable), ubc3/cdc34 (inviable), ubc6 (unavailable),
and ubc9 (required for SUMOylation rather than ubiquitination).
Expression plasmids used in this study were those containing STE2,
GPA1, STE4, STE18, and SST2. Each gene was amplified using flank-
ing PCR primers that anneal 600 bp upstream or 600 bp downstream of
the open reading frame. The PCR products were then subcloned by
digestion with BamHI and either KpnI (SST2 and STE4) or XhoI
(STE2, GPA1, and STE18) (restriction site encoded by the PCR prim-
ers) and ligation to pRS316 (18). Other plasmids described previously
are SST2-myc (12) expressed in pRS316-ADH (19) (plasmid pRS316-
ADH-SST2-myc) and FUS1-GFP reporter (plasmid pDS30, from Daria
Siekhaus, University of California, Berkeley) (20). Methods for purifi-
cation of Sst2 (21) and Gpa1 (13) were described previously.
Signaling, Expression, Ubiquitination, and Degradation Assays—
The pheromone-dependent transcription assays using the -galactosid-
ase (22) and green fluorescent protein (23) reporters have been de-
scribed previously. For immunoblot detection, cell growth was stopped
by the addition of 10 mM NaN3 and transfer to an ice bath. To monitor
the degradation of Sst2 over time, mid-log cell cultures were treated
with cycloheximide (10 g/ml in 0.1% ethanol, final concentrations) for
up to 120 min before harvesting. Cells were washed and resuspended
directly in boiling SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8,
10% glycerol, 2% SDS, 1% 2-mercaptoethanol, 0.0005% bromphenol
blue) for 10 min, subjected to glass bead homogenization, and clarified
by microcentrifugation. Following SDS-polyacrylamide gel electro-
phoresis and transfer to nitrocellulose, the membrane was probed with
antibodies to Ste2 at 1:2,000 (from James Konopka, State University of
New York), Gpa1 at 1:1,000 (24), Ste4 at 1:2,000 (from Duane Jenness,
University of Massachusetts), Ste18 at 1:100 (yN-16, Santa Cruz Bio-
technology, Inc.), Sst2 at 1:2,000 (12), Myc (9E10) at 1:1,000 (25), or
ubiquitin at 1:100 (Sigma). Immunoreactive species were visualized by
enhanced chemiluminescence detection (Pierce) of horseradish peroxi-
dase-conjugated anti-rabbit IgG (Bio-Rad) or anti-goat IgG (Santa Cruz
Biotechnology, Inc.). Specificity of antibody detection was established
using gene deletion mutants, diploid cells (which do not express the
receptor, G protein, or RGS protein), or non-Myc-tagged SST2 as neg-
ative controls.
Ubiquitinated Sst2 was enriched by immunoprecipitation prior to
immunoblotting. Cells were grown to mid-log phase and either treated
with 3 M -factor or with water for 1 h. Approximately 100 ml of cells
at A600 nm  1 were harvested and lysed at 4 °C in 600 l of lysis buffer
(25 mM Tris-HCl, pH 7.4, 200 mM NaCl, 15 mM EGTA, 15 mM MgCl2,
0.1% Triton X-100, 10% glycerol, 1 mM NaN3, 1 mM dithiothreitol, 10
mM N-ethylmaleimide, 5 mM phenylmethylsulfonyl fluoride, 1 g/ml
pepstatin, and 1 g/ml leupeptin) with the use of acid-washed glass
beads and 30-s pulses of vortexing, repeated six times. Samples were
centrifuged for 10 min at 6,500  g, and the resulting supernatant was
removed and diluted to a final volume of 1 ml with wash buffer (the
same as lysis buffer except there is no glycerol). Lysates were incubated
with 40 l of 9E10 anti-Myc antibodies for 90 min on ice. After clarifi-
cation with a 10-min high speed microcentrifugation at 4 °C, protein-
antibody complexes were precipitated for 1 h at 4 °C with 40 l of a 50%
slurry of protein G-Sepharose (Amersham Biosciences) equilibrated in
wash buffer. Immunoprecipitates were collected by centrifugation at
2,000  g for 30 s, and pellets were washed with wash buffer before
final resuspension in 50 l of 2 SDS-PAGE sample buffer.
Deterministic Modeling of Regulation by Sst2—To help elucidate the
mechanism by which Sst2 regulates the pheromone response pathway,
we constructed a simple mathematical model of the system. The vari-
ables in the model are the time-dependent concentrations of Ste4/Ste18
([G]) and Sst2 ([RGS]). We assumed that the total concentration of
G, [G]T  [G]  [G
GDP], is constant in time. We also assumed
that the rate-limiting step in the reformation of GGDP after exposure
to pheromone is the hydrolysis of GTP. Once hydrolysis occurs, GGDP
and G rapidly combine to produce GGDP. The dynamics of [G] is
governed by the ordinary differential equation.
dG
dt
 k1  fk1	
GT  G
  k2GGTP  k3RGSGGTP
(Eq. 1)
The first term on the right-hand side of Equation 1 represents the rate
at which free G is liberated from GGDP. The parameter k1 is the
rate constant for the process in the absence of pheromone, and k1	 is the
pheromone-induced rate constant. The fraction of ligated receptors at
pheromone concentration [L] is given by f  [L]/(K  [L]), where K is the
effective dissociation constant for ligand binding. The second term on
the right-hand side of Equation 1 represents the loss of free G by
RGS-independent formation of GGDP. The reason this term does not
explicitly depend on [G] is because of our assumption that, after
exposure to pheromone, GTP hydrolysis is the rate-limiting step in the
reformation of GGDP. The final term models the acceleration of this
process by RGS (negative feedback). k2 are k3 are the corresponding rate
constants for these two processes. By assuming that the total G
concentration, [G]T  [G
GDP]  [GGDP]  [GGTP], is constant in
time and that [GGDP]  0, [GGTP] can be written in terms of [G] as
follows: [GGTP]  [G]T  [G]T  [G]. Making this substitution in
Equation 1 produces the following equation.
dG
dt
 k1  fk1	
GT  G

 k2  k3RGS
GT  GT  G
 (Eq. 2)
For the wild-type strain, we assumed that [G]T  [G]T, and for the
strain in which G is doubly expressed, we assumed [G]T is present
at twice the wild-type level.




 k4  k5G  RGS (Eq. 3)
where k4 is the constitutive rate of RGS production, k5 is the phero-
mone-induced rate of RGS production, and  is the degradation rate of
RGS. While Equations 2 and 3 lack many biological details, it is shown
under “Results” that this simple model provides insight into the signal-
ing pathway. Equations 2 and 3 were solved numerically using MatLab.
The pheromone-dependent transcriptional induction curves shown in
Figs. 2C and 3B were produced from the relation R  [G]ss/([G]ss 
	), where R is the response, [G]ss is the steady-state value of [G],
and 	 is the value of [G] at which the response is half its maximum
value. Equation 2 can be used to write R in terms of [L] and the
steady-state RGS concentration [RGS]ss. The result is given by Equa-
tion 10 where Rmin, Rmax, and C are defined as follows.
Rmin 
GTk1  k2  k3RGS
GT  GT

	k1  k2  k3RGS












  k2  k3RGS
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  k2  k3RGS




The parameter values used to produce Figs. 2C, 3B, and 4 are k1 
5.25  105 min1, k1	  1.75 min
1, K  2.0  103 mM, [L]  3  103
mM, [G]T  2  10
4 mM, k2  3.5  10
3 min1, k3  3,500 min
1
mM1, k4  2.5  10
6 mM min1, k5  2.5  10
2 min1,   5  102
min1, and 	  2.0 mM.
To simplify the model further, we made the reasonable assumption
that changes in free G occur on a much shorter time scale than
changes in RGS expression. That is, we assumed that [G] is in
equilibrium with respect to the current RGS expression level. Mathe-
matically this means that the time derivative in Equation 2 is equal to
zero. Solving the resulting equation for [G] and substituting the











 RGS (Eq. 7)
where S  k5[G]T(k1  fk1	)/k3 and Knf  (fk1	  k1  k2)/k3, and we
made the simplifying assumption that [G]T  [G]T. In the above
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equation, the negative effect of RGS is clear. The maximum response in
the absence of RGS is S/Knf. As [RGS] increases, the production rate
returns to k4.
Stochastic Modeling of Sst2/RGS Inhibition—Whereas determinis-
tic models describe the average behavior of a number of individual cells,
stochastic models describe the diverse behavior of many individual cells
as well as the random changes within a single cell. To illustrate that
pheromone-induced Sst2 degradation through ubiquitination is suffi-
cient to explain the experimental results obtained for the 2xSST2










The function g models the effect of pheromone-induced ubiquitination
and increases the degradation rate. We assumed that RGS inhibits its
own degradation, which would be the case if free G initiated the







where gmax is the maximum value of g, and KRGS determines where g
reaches half its maximum value. Finally we added a noise term in
Equation 8 to model fluctuations in the concentration due to the sto-
chastic nature of chemical reactions. In general, the strength of the
noise depends on the biochemical reactions in the signaling pathway
(26). However, for simplicity we modeled this term as Gaussian white
noise of strength D. Equation 8 was solved numerically using an Euler
method, and 10,000 realizations of the process were used to produce the
results shown in Fig. 6, B and C. The parameter values used in these
figures are k4  0.02, S  0.36, Knf  0.09, KRGS  0.35, [L] gmax  0.9,
  0.2, and D  0.0001.
RESULTS
Our goal in this work was to understand how external sig-
nals produce responses within the cell. Our focus was on G
protein activation, desensitization, and eventual resensitiza-
tion by receptors and RGS proteins. Since an accurate model of
any biological system requires knowledge of the identity and
quantity of its components, we began by determining the
amount of the RGS (Sst2) and G (Gpa1) present in the cell.
The G subunits Ste4 and Ste18 were presumed to be ex-
pressed at levels equal to Gpa1 since G protein subunits as-
semble in a 1:1:1 stoichiometry, and Ste4 and Ste18 do not bind
to any other G in yeast. Receptor expression was determined
by radioligand binding measurements to be 8,000/cell (27).
TABLE I
Protein expression
Numbers in parentheses are maximum values (after pheromone
treatment).
Protein Number/cell Source
Receptor (Ste2) 8,000 Ref. 27
G (Gpa1) 8,000 (12,000) Experimental measurement
G (Ste4) 8,000 Inferred
G (Ste18) 8,000 Inferred
RGS (Sst2) 2,000 (5,000) Experimental measurement
FIG. 1. Time course of RGS and G protein induction after
pheromone stimulation. A, to determine the levels of expression of
Sst2 and Gpa1 in yeast, known amounts of purified recombinant pro-
tein (standard) were mixed with whole-cell lysates from gpa1 and
sst2 mutants, respectively, resolved by 7.5% SDS-PAGE and immu-
noblotting, and probed with anti-Gpa1 and anti-Sst2 antibodies as
indicated (IB). To estimate the relative protein expression the bands
were analyzed by densitometric scanning. Calculated expression levels
of endogenous Gpa1 and Sst2 with () and without () 1-h treatment
with 3 M -factor are summarized in Table I. Note that a portion of
endogenous Gpa1 and none of the Escherichia coli-expressed Gpa1 is
myristoylated (Myr-Gpa1) as reported previously (24, 44). B, whole-cell
extracts were prepared from wild-type (BY4741) cells transformed with
a single copy plasmid (pRS316) containing genomic SST2 (2xSST2) or
no insert and treated with 3 M -factor for the indicated times. Sam-
ples were resolved by 7.5% SDS-PAGE and immunoblotting and probed
using anti-Gpa1, anti-Ste4, or anti-Sst2 polyclonal antiserum as indi-
cated (IB). The upper Ste4 band corresponds to the phosphorylated form
of the protein and is induced by pheromone (28). The specificity of each
antibody was confirmed using gene deletion or diploid cells lacking the
indicated gene product (not shown). To estimate the difference in pro-
tein expression the Sst2 band was analyzed by densitometric scanning
(bottom panel). The data shown are representative of two independent
experiments. WT, wild type; IB, immunoblot; Mol., molecules.
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To measure expression of Sst2 and Gpa1, we performed
quantitative immunoblotting of whole-cell extracts. Cells in
mid-log phase were harvested, lysed directly in SDS-PAGE
sample buffer, and resolved by gel electrophoresis and immu-
noblotting. Absolute expression levels were determined using
standards in which known quantities of purified recombinant
Sst2 or Gpa1 were mixed with lysates from sst2 or gpa1
mutants, respectively. These data reveal that each cell con-
tained 8,000 copies of Gpa1, equal to the number of receptors,
and 2,000 copies of Sst2 (Fig. 1A and Table I).
Since the genes that encode GPA1 and SST2 are induced
upon pheromone stimulation, we also monitored the expression
levels of the encoded proteins over the course of a 2-h treatment
with -factor. The relative expression of each protein was again
FIG. 2. Double expression of Ste4 activates the mating pathway. Pheromone-dependent transcriptional induction was measured following
transformation of wild-type cells with a single copy plasmid (pRS316) containing genomic STE2 (2xSTE2), GPA1 (2xGPA1), or STE18 (2xSTE18)
(A) or STE4 (2xSTE4) (B) and co-transformation with a pheromone-responsive FUS1 promoter-lacZ reporter (pRS423-FUS1-lacZ). Cells were then
treated with the indicated concentrations of -factor for 90 min, and the resulting -galactosidase activity was measured spectrofluorometrically.
Activity is given in arbitrary units. To avoid selection for spontaneous sterile mutations the STE4-overexpressing cells were co-transformed with
GPA1 under control of the GAL1/10 promoter (pRS315-GAL-GPA1) and maintained in galactose medium until the final inoculation into dextrose
medium prior to performing the experiment. Insets, to confirm double expression of each gene product, the same cells were lysed and analyzed by
immunoblotting with anti-Ste2, anti-Gpa1, anti-Ste4, or anti-Ste18 polyclonal antibodies. The data shown are representative of at least two
independent experiments performed in triplicate. C, predicted pheromone-dependent transcriptional induction for the wild-type (WT) (solid line)
and 2xSTE4 (dot-dashed line) strains. The model accurately captures the increased activity over the entire range of pheromone concentrations
observed above for doubled expression of STE4. The response is scaled relative to the maximum response in wild-type cells (response  1). Details
of the model and the parameter values used to produce these and subsequent results are given under “Experimental Procedures.”
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determined by immunoblotting (Fig. 1B). These data reveal
that Sst2 was induced 2.5-fold after 1 h of treatment and then
declined slightly during the remainder of the experiment. Gpa1
expression was increased by 50% and remained elevated even
after 2 h. Ste4 expression was not altered, although it does
undergo a mobility shift as a result of pheromone-dependent
phosphorylation (28). These results are summarized in Table I.
We also examined whether perturbations in the expression
of each signaling component would alter the pheromone re-
sponse. Cells expressing normal amounts of Sst2, receptor, and
all three G protein subunits were compared with cells engi-
neered to express double (“2x”) the normal amount of each
component (Figs. 2 and 3). For this purpose, genomic copies of
STE2, GPA1, SST2, STE4, and STE18 were subcloned into a
centromere-based shuttle vector and transformed into wild-
type cells. An sst2 mutant was also tested since that would
provide information about pathway activation in the absence of
feedback inhibition and GTPase acceleration. Other deletions
lead to permanent activation of the pathway (gpa1) or a
complete loss of responsiveness (ste2, ste4, and ste18) and
were not tested (6). Changes in protein expression were con-
firmed in each case by immunoblotting using polyclonal anti-
bodies against Ste2, Gpa1, Ste4, and Sst2. Alterations in pher-
omone sensitivity were measured using a reporter
transcription assay comprised of a pheromone-responsive pro-
moter (from FUS1) fused to lacZ (-galactosidase). This partic-
ular assay was chosen because it is sensitive, quantitative, and
highly specific for Gpa1 signaling (22). We chose not to use
fluorescence-based measures of G protein dissociation because
they require modifications or fusions that might alter G protein
stability, localization, or activity (29).
As shown in Fig. 2, 2-fold overexpression of the receptor, G
protein -subunit, and G subunit had no effect on pheromone
sensitivity. In contrast, overexpression of G produced a dra-
matic increase in activity over the entire range of pheromone
concentrations. Basal activity (no pheromone added) was also
elevated so that it was nearly equivalent to wild-type cells
treated with a maximally effective dose of pheromone. Thus
2-fold overexpression of G is sufficient to fully activate the
pathway. This is consistent with the model that G is neces-
sary and sufficient for pathway activation and that G is the
limiting component of the G heterodimer complex (30). Two-
fold overexpression of SST2 led to a reduction in the maximum
response by 27% (Fig. 3A). Deletion of SST2 did not alter the
maximum response but rather resulted in a 100-fold decrease
in the concentration of -factor necessary to achieve 50% of the
maximum agonist response (EC50) (Fig. 3A). These data reveal
that, while loss of SST2 affected potency (a decrease in EC50),
overexpression of SST2 caused a decrease in efficacy or maxi-
mum response.
Having established for each component the expression levels
and functional consequences of altered expression (Figs. 2 and
3), we devised a simple mathematical model to describe path-
way activation and inactivation with a set of two coupled ordi-
nary differential equations. A detailed description of the mod-
eling is provided under “Experimental Procedures” and is
shown schematically in Fig. 4A. The model assumes that G is
produced in excess of G (but G is limiting so final expression
levels are equal) and that receptor and G are present in equal
amounts and are always associated so that individually chang-
ing the concentration level of G, receptor, and G does not
affect the model. These assumptions were consistent with data
shown in Fig. 2 for the double expression of Ste18, Ste2, and
Gpa1. Thus the model only considers G and the RGS protein.
Free G activates the intracellular signal leading to new gene
expression, and the RGS protein has a negative effect on the
pathway by increasing the rate at which G recombines with
GGDP. The model produces several predictions that can be
compared with the experimental results presented above. Typ-
ical time series generated by the model for release of free
Ste4/Ste18 ([G]) and the expression of Sst2 ([RGS]) are
shown in Fig. 4B. The model predicts a sharp initial increase of
free G in response to pheromone followed by a slow decrease
as the Sst2 concentration begins to rise. The initial slow rise in
Sst2 expression is in good qualitative agreement with data
shown in Fig. 1B for the wild-type (WT) strain. However, the
model cannot reproduce the slow decline in Sst2 levels seen at
later times (see below). The model can be used to derive an
expression for response R of the signaling pathway as a func-
tion of pheromone concentration [L]. The general form of this





FIG. 3. Double expression of Sst2 attenuates the response to
pheromone. A, pheromone-dependent transcriptional induction was
measured following transformation of wild-type cells with a single copy
plasmid (pRS316) containing genomic SST2 (2xSST2), transformation
of wild-type cells with the same plasmid containing no insert (WT), or
transformation of an sst2 mutant with plasmid containing no insert
(sst2). The same cells were co-transformed with a pheromone-respon-
sive FUS1 promoter-lacZ reporter. Cells were then treated with the
indicated concentrations of -factor for 90 min, and the resulting -ga-
lactosidase activity was measured spectrofluorometrically. Inset, to con-
firm expression of Sst2, the same cells were lysed and analyzed by
immunoblotting with anti-Sst2 polyclonal antibodies. The data shown
are representative of at least two independent experiments performed
in triplicate. B, predicted pheromone-dependent transcriptional induc-
tion for the three strains shown in A. The model captures the decrease
in EC50 seen in the sst2 strain (dashed line) relative to the wild-type
strain (solid line). However, it cannot fully account for the decrease in
the maximal response seen in the 2xSST2 strain (dot-dashed line)
without also producing an artificial increase in the maximal response of
the sst2 strain. The response is scaled relative to the maximum re-
sponse in wild-type cells (response  1).
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where Rmin is the response in the absence of pheromone, and
Rmax is the maximum response. Explicit expressions for Rmin,
Rmax, and C in terms of [L], steady-state RGS concentration,
and the model parameters are provided under “Experimental
Procedures.” As can be seen from Fig. 2C, the model correctly
captures the increased response over the entire range of pher-
omone concentration where G is overexpressed (Fig. 2B). The
model also captures the dependence of the EC50 on Sst2 (com-
pare Fig. 3, A and B).
There are two qualitative features of the data that are not
captured by the model. First, deletion of SST2 had no affect on
the maximum response, whereas 2-fold overexpression of SST2
produced a 27% reduction in the maximum response (Fig. 3A).
The model cannot simultaneously account for both observa-
tions. Second, in the strain containing two copies of SST2 the
expression level was relatively constant at early times follow-
ing pheromone addition and then increased sharply between 60
and 105 min (Fig. 1B). The initial slow increase in Sst2 expres-
sion followed by a rapid increase in expression is not consistent
with the model.
To investigate the discrepancies between the experimental
results and the model predictions, the transcription assay was
repeated using the green fluorescent protein (GFP) instead of
-galactosidase as a reporter. The use of GFP allows the activ-
ity of individual cells to be measured by flow cytometry (20, 23).
Wild-type cells containing a single copy plasmid containing no
insert or a genomic SST2 clone (2xSST2) were treated with
-factor for 90 min. As shown in Fig. 5 there is in all cells a
single peak of low intensity fluorescence (peak activity between
10 and 100 units) in the absence of pheromone, which upon
pheromone treatment is diminished and replaced by a second
peak of higher intensity (peak activity between 100 and 1000
units) (23). Whereas the shift from low intensity to high inten-
sity was nearly complete under normal conditions, a prominent
low intensity peak persisted in cells that overexpress SST2.
These data indicate that the reduced maximum response seen
in Fig. 3A is most likely due to a subpopulation of cells that is
completely unresponsive. Whereas the response to pheromone
is normally graded, it can become binary (all-or-none) when
Sst2 is overexpressed.
One way that binary responses can occur is through positive
feedback regulation (31). Thus we considered a phenomenolog-
ical model in which pheromone promotes a second feedback
loop leading to faster Sst2 degradation (see “Experimental
Procedures” for details of the model). The model makes the
reasonable assumption that alterations in the expression of
Sst2 occur more slowly than alterations in the activation state
of the G protein. Stated differently, the activation state of the
G protein adjusts rapidly to the slow variation in Sst2 concen-
tration and is therefore assumed to be in equilibrium. This
assumption allows the state of the system to be determined by
Sst2 expression levels alone. The model for the 2xSST2 strain
is shown schematically in Fig. 6A. The rates of Sst2 production
(solid lines) and degradation (dashed lines) are shown as a
function of Sst2 expression. The two straight lines represent
Sst2 production and degradation rates in the absence of pher-
omone. In this case production was independent of Sst2 expres-
sion, while degradation was proportional to Sst2 expression.
FIG. 4. Pathway regulation by RGS and G proteins. A, upon
binding of the ligand (L) -factor (F) to its receptor (R, Ste2), the G
protein  subunit (Gpa1) releases GDP, binds to GTP, and liberates the
G protein  subunits (Ste4/Ste18). Sustained signaling requires acti-
vation of multiple effectors (not shown) by the dissociated G compo-
nents. These effectors activate a pathway (dotted line) leading to tran-
scription of several genes including the RGS protein (Sst2). GTP
hydrolysis is accelerated by the RGS protein, and this leads to subunit
reassociation and pathway inactivation. The model assumes that GTP
hydrolysis is the rate-limiting step of subunit reassembly. A potential
positive feedback loop leading to Sst2 degradation is indicated by a
darker line. B, in the computer simulation the concentration of free G
(solid line) increases rapidly after addition of pheromone (at time  0).
The concentration of RGS (dashed line) responds slowly and eventually
inactivates the pathway leading to a reduction in free G. The exper-
imentally observed induction of Sst2 (from Fig. 1B) is also shown (solid
circles). The details of the model and parameter values used in the
computer simulation are presented under “Experimental Procedures.”
FIG. 5. Double expression of Sst2 eliminates the response in a
subpopulation of cells. Pheromone-dependent transcriptional induc-
tion was measured following transformation of wild-type cells with a
single copy plasmid (pRS316) containing genomic SST2 (2xSST2) or
transformation of wild-type cells with the same plasmid containing no
insert (WT). The same cells were co-transformed with a pheromone-
responsive FUS1 promoter-GFP reporter. Cells were then treated with
-factor for 90 min, and the resulting fluorescence in each cell was
monitored by cell sorting. Pathway activation results in an increase in
cells with 100 fluorescence units of activity. The peak below 10 units
is also seen in cells lacking the reporter and likely represents autofluo-
rescence noise.
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Where the lines intersect production and degradation rates are
equal (“constitutive steady state”). The two curved lines repre-
sent Sst2 production and degradation rates in the presence of
pheromone. At low Sst2 expression, the induced production
rate exceeded the constitutive production rate. At higher Sst2
expression the pathway was inhibited, SST2 transcription was
diminished, and the induced production rate approached the
constitutive rate. The degradation rate also had a non-linear
dependence on Sst2 expression. At low Sst2 expression, pher-
omone promoted Sst2 degradation as part of a positive feed-
back mechanism. At higher Sst2 expression the pathway was
inhibited, Sst2 degradation was diminished, and the induced
degradation rate approached the constitutive rate. Where the
lines intersect production and degradation rates are equal (“in-
duced steady state”).
Using the revised model we can understand the slow initial
induction of Sst2 seen for the 2xSST2 strain (see Fig. 1B).
Initially the system is in steady state ([Sst2]  0.4). After
exposing the cells to -factor, the production rate exceeds the
degradation rate slightly, and the Sst2 levels slowly increase.
As Sst2 expression increases the degradation rate falls more
rapidly than the production rate, and eventually the level of
Sst2 begins to rise until it reaches a new steady state ([Sst2] 
1.2). The dot-dashed line in Fig. 6B is a time series produced by
this model and shows good qualitative agreement with the
experimental results in Fig. 1B. For simulation of the 2xSST2
strain, the constitutive and pheromone-induced production
rates were double that of the wild-type strain.
In the model described above, even for the 2xSST2 strain,
there is only one steady state. To test whether this model can
reproduce the binary response seen in the single cell transcrip-
FIG. 7. Pheromone stimulation promotes the degradation of
Sst2. An sst2 mutant strain transformed with a single copy plasmid
(pRS315-ADH) containing SST2 under the control of a constitutive
promoter (from ADH1) (A) or wild-type cells expressing genomic SST2
and the native promoter (pRS315) (B) were treated with 3 M -factor
for 60 min and then treated with the protein synthesis inhibitor cyclo-
heximide (CHX) for the indicated times. Cell extracts were analyzed by
immunoblotting with anti-Sst2 antibodies as described in Fig. 1. To
estimate the difference in protein half-life the intensity of each band
was analyzed by densitometric scanning. The data are representative of
one (A) or two (B) independent experiments. IB, immunoblot.
FIG. 6. Modeling Sst2 inhibition. A, Sst2 production rates (solid
lines) and degradation rates (dashed lines) as a function of Sst2 con-
centration. The two straight lines are the constitutive rates. Where the
lines intersect represents a steady state (Constitutive steady state). The
upper curves are the pheromone-induced rates. At moderate Sst2 levels,
pheromone-induced expression and degradation are enhanced and al-
most equal causing the system to respond slowly. At high Sst2 levels the
pathway is inhibited, so transcription and degradation of Sst2 are also
diminished and eventually reach a new steady state (Induced steady
state). B, time courses generated by the model depicted in A. The slow
response of the system at early times is clearly visible. The solid line is
the result from the model in the absence of stochastic effects. The
dot-dashed line is the average result for the stochastic model. Details of
the model and parameter values are given under “Experimental Proce-
dures.” C, a histogram of the data generated by the stochastic model of
Sst2 inhibition. The dashed vertical line indicates the time at which
samples were collected and clearly shows a binary response that is
transient and disappears at later times. Values for Sst2 concentration
and times are arbitrary.
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tion assay shown in Fig. 5 we added a stochastic term to the
model to account for random fluctuations in protein concentra-
tions levels. We then performed 10,000 simulations of the ran-
dom model and averaged the results to yield the mean time
course indicated by the solid line in Fig. 6B. Fig. 6C is a
histogram of the modeled Sst2 concentrations for each simula-
tion at single time points indicated by the vertical line at
time  22 (Fig. 6B). The results presented in Fig. 6C show a
clear binary response similar to that observed for the 2xSST2
strain (Fig. 5).
Taken together, the revised model requires the existence of a
positive feedback mechanism leading to pheromone-dependent
loss of Sst2. Thus we investigated whether pheromone treat-
ment does in fact promote the degradation of Sst2. After 1 h of
growth in the absence or presence of pheromone the cells were
treated with cycloheximide to block new protein synthesis.
Steady-state levels of Sst2 remaining were then monitored by
immunoblotting. As shown in Fig. 7, Sst2 abundance declined
more quickly when pretreated with pheromone. A similar pat-
tern of degradation was observed when SST2 was expressed
from a constitutive promoter (Fig. 7A) or the native promoter
(Fig. 7B). These data indicate that pheromone stimulates the
degradation of Sst2 as predicted by the model.
We then investigated whether pheromone-dependent Sst2
degradation results from ubiquitination, a modification that
has been reported for some mammalian RGS proteins (32, 33).
Ubiquitination is the formation of an isopeptide bond between
the ubiquitin polypeptide and Lys side chains of the target
protein (34). Ubiquitin is itself ubiquitinated, resulting in the
formation of polyubiquitin chains. The polyubiquitinated pro-
tein is usually then captured and degraded by a large protease
complex, the 26 S proteasome (35). To determine whether Sst2
is ubiquitinated we analyzed the expression of a Myc epitope-
tagged version of the protein. As shown in Fig. 8A, long expo-
sures of Sst2-myc immunoblots revealed a very high molecular
weight immunoreactive band, suggesting that the protein is
indeed polyubiquitinated. This high molecular weight species
was barely visible in the untreated cells but accumulated with
FIG. 8. Pheromone promotes the
ubiquitination of Sst2. A, wild-type
cells were transformed with pRS316-
ADH-SST2-myc and treated with 3 M
-factor for the indicated times. Whole-
cell lysates were then prepared and re-
solved by 7.5% SDS-PAGE and immuno-
blotting. Monoclonal anti-Myc antibodies
detected the Myc epitope-tagged Sst2-myc
(Sst2) and a broad high molecular weight
species corresponding to a likely ubiquiti-
nated form of Sst2 (Ubi-Sst2) that accu-
mulated over time. B, to confirm that the
high molecular weight species is in fact
Sst2, wild-type cells were transformed
with the Myc-tagged form of Sst2 and
probed with anti-Myc monoclonal anti-
bodies. The high molecular weight species
was recognized by the anti-Myc antibody,
accumulated with pheromone treatment,
and was absent in the control cells trans-
formed with an empty vector or another
Myc-tagged protein (Rgs2) (left panel).
The Sst2 species detected with the Myc
antibodies was also detected using the an-
ti-Sst2 antibodies (right panel). C, to con-
firm ubiquitination of Sst2 the same cells
were immunoprecipitated with anti-Myc
antibodies (IP), resolved by 7.5% SDS-
PAGE and immunoblotting, and probed
with anti-ubiquitin antibodies (IB). Data
are representative of at least two inde-
pendent experiments. IB, immunoblot;
Ubi, ubiquitin.
Feedback Regulation of G Protein Signaling 46513
time and became fully modified after 60 min of pheromone
treatment. To confirm that the high molecular weight band is
Sst2 we demonstrated that it is recognized by anti-Sst2 as well
as anti-Myc antibodies (Fig. 8B). As an additional control we
constructed a Myc-tagged version of a second RGS protein in
yeast, Rgs2. Rgs2 regulates Gpa2 specifically, having no effect
on the Gpa1-mediated pheromone response (36). As shown in
Fig. 8B, Rgs2 did not exhibit any change in mobility either in
the absence or presence of pheromone. To confirm that the
appearance of a high molecular weight form of Sst2 is due to
ubiquitination, the protein was immunoprecipitated with anti-
Myc antibodies and analyzed by immunoblotting with anti-
ubiquitin antibodies. This enrichment scheme again yielded a
high molecular weight band recognized by both anti-ubiquitin
and anti-Myc antibodies (Fig. 8C).
The data presented above indicate that pheromone promotes
the ubiquitination and degradation of Sst2. To determine
whether ubiquitination of Sst2 leads to degradation, we
searched for mutants that diminish Sst2 ubiquitination and
investigated their effects on Sst2 turnover. Ubiquitination typ-
ically requires three distinct enzymatic activities: a ubiquitin-
activating enzyme (E1), a ubiquitin-conjugating enzyme (E2),
and a ubiquitin ligase (E3). For our experiments we tested
strains lacking E2 ubiquitin-conjugating enzymes since most
E2-encoding enzymes are not essential, and their identity is
more clearly defined than the E3 enzymes. All available E2-
deficient deletion mutants were treated with pheromone for 1 h
and then analyzed by immunoblotting with anti-Sst2 antibod-
ies. As shown in Fig. 9A, Sst2 ubiquitination was diminished in
the E2 mutant ubc2 but was preserved in all the other mutant
and wild-type strains tested.
We then compared the turnover rate of Sst2 in ubc2 mutant
and wild-type cells both in the absence and presence of phero-
mone. Cells in mid-log phase were treated with cycloheximide
to block new protein synthesis and analyzed by immunoblot-
ting with anti-Myc antibodies. As shown in Fig. 9B the overall
level of Sst2 dropped rapidly when translation was blocked in
wild-type cells, while the half-life was extended dramatically in
the ubc2 mutant. We conclude from these results that Sst2
degradation is slowed when it is no longer ubiquitinated. Taken
together, our findings indicate that pheromone promotes not
only the transcription of SST2 but also the ubiquitination and
subsequent degradation of the protein. Together these mecha-
nisms could account for the transient expression of the protein
following pheromone challenge.
DISCUSSION
Biologists have traditionally described the cellular functions
of proteins in qualitative terms with models based largely on
intuition. Such models typically ignored temporal aspects of
protein activity and therefore failed to predict behavior result-
ing from changes in protein expression and turnover. More-
over, while cellular metabolic or signaling pathways were once
described as linear and unidirectional, they are now recognized
to consist of complex networks subject to positive and negative
feedback regulation. As our understanding of these pathways
becomes more sophisticated, however, it has become possible to
devise models that can account for their complex behaviors and
are therefore more accurate, comprehensive, and quantitative.
Our ability to identify genes, manipulate their expression, and
quantify their function has also improved to the point where
computation models can be reasonably tested experimentally.
Here we devised a quantitative model that considers the
activation, desensitization, and resensitization steps following
pheromone stimulation in yeast. This approach allowed us to
demonstrate the importance of negative feedback inhibition
through induction of RGS expression (desensitization) and also
prompted our discovery of a positive feedback loop leading to
RGS ubiquitination and degradation (resensitization). Only by
taking into account this second feedback loop were we able to
adequately explain the available functional data.
The existence of both positive and negative controls on RGS
protein expression, acting in sequence, could serve as a timing
mechanism to allow multiple rounds of pathway activation. If
G protein activation occurred without RGS induction the sys-
tem would reach a stable and non-productive “on” state. Con-
versely RGS degradation may be required to eventually restore
pheromone responsiveness in haploid cells, thereby increasing
the prospect of a second chance at successful conjugation.
Sst2 joins a small but growing list of signaling proteins that
undergo ubiquitination. In the pheromone response pathway,
receptors (37–39), the G subunit (40, 41), and the effector
kinase Ste7 (42, 43) are known substrates for ubiquitination.
Ubiquitination of Ste7 is dependent on prolonged pheromone
stimulation, and once ubiquitinated it is rapidly degraded by
the proteasome (42, 43). Ubiquitination of the receptor is also
accelerated by pheromone. However, this situation is unusual
in that the receptor is monoubiquitinated rather than polyu-
biquitinated, and ubiquitination in this case serves as a signal
for endocytosis and delivery to the vacuole instead of the pro-
teasome (37–39). Ubiquitination of the G protein is not regu-
lated by pheromone but is noteworthy because it was the first
FIG. 9. Ubiquitination of Sst2 promotes degradation. A, wild-
type strains or isogenic mutant strains lacking the indicated gene were
transformed with pAD4M-SST2 and treated with 3 M -factor for 60
min. Cell extracts were analyzed by immunoblotting with anti-Sst2
antibodies. Of the strains tested, only ubc2 mutants exhibited dimin-
ished ubiquitination of Sst2. B, to determine whether diminished ubiq-
uitination results in diminished degradation, wild-type and ubc2 cells
were transformed with pRS316-ADH-SST2-myc. Cells were treated
with 3 M -factor and cycloheximide as indicated. Cell extracts were
then resolved by SDS-PAGE and immunoblotting with anti-Myc anti-
bodies to detect Sst2 remaining. Data are representative of at least two
independent experiments. Ubi, ubiquitin; IB, immunoblot; WT, wild
type; CHX, cycloheximide.
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ubiquitination site to be directly mapped by mass spectrometry
(41).
Biologists and applied mathematicians have long used sim-
ilar methods to describe input-output relationships of complex
systems. The dose-response profiles so familiar to biologists are
equally well known to theorists, who refer to them as one-
parameter bifurcation diagrams (31). Dose-response profiles
are used by pharmacologists and physiologists to predict the
response of a cell to a specific dose of drug or hormone. Such
profiles are also useful to theorists because they summarize the
general, qualitative properties of solutions of a set of non-linear
differential equations. However, because theorists are not con-
strained by the same technical and ethical considerations that
preclude certain biological experiments they may be able to
describe or interpret cellular behavior in ways that experimen-
talists cannot and therefore have the potential to greatly enrich
our understanding of biological systems. An example of this
potential was realized here in our ability to devise a model of
response regulation by Sst2. While the model did not explicitly
account for every biochemical step in the pathway, it was
consistent with the known biology of G protein signaling. An
advantage of using this simple model was that it allowed us to
make several predictions that could be compared with experi-
mental data. In particular, we found that the model could not
simultaneously account for the behavior of the 2xSST2 strain,
the sst2 mutant, and the wild-type strain at saturating pher-
omone levels. The model could also not reproduce the slow
induction of Sst2 expression observed for the 2xSST2 strain.
The inconsistencies prompted further experiments, which in
turn led to a revised model.
In summary, our analysis accounts for three key aspects of G
protein-mediated signaling. The signal initiation step, already
well established, requires receptor-catalyzed guanine nucleo-
tide exchange. The second step consists of a negative feedback
loop by which pheromone promotes RGS expression and G
protein inactivation. RGS proteins were already well known to
inhibit signaling, but the contribution of transcriptional induc-
tion had not previously been demonstrated. The third step was
previously unknown and invokes a positive feedback mecha-
nism through induction of RGS protein ubiquitination and
degradation. These findings illustrate how computational mod-
eling, which is not by itself hypothesis-driven, can generate a
novel hypothesis about protein function that can be tested
experimentally.
Having described the activity of the early steps in the pher-
omone signaling pathway, our present goal is to model activa-
tion of downstream effectors and eventually create computer
simulations of the entire pathway. This should be feasible
given that there are relatively few components, and their ac-
tivities are well understood. Such studies should provide new
insights about how cells communicate and respond to external
stimuli and how those responses change over time. The combi-
nation of experimental and computational approaches used
here could also be applied to other signaling pathways and
other organisms and promises to improve our understanding of
how cellular changes in disease states can be predicted and
managed.
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